A prospective open labeled clinical trial to evaluate the efficacy and safety of â??HAIRAL 7â?? in hair regrowth and in the treatment of dandruff and hair loss in female and male patients. - HAIRAL 7 study

ABS LABORATORIES0 sites60 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

September 21, 2012

Last Updated

4 years ago

Study Type

Interventional

Sponsor

ABS LABORATORIES

•ï??Males and females of age group 18\-40 years
•ï??Subjects who are suffering from mild to moderate hair loss and/or Subjects suffering from mild to moderate dandruff.
•ï??Subjects who are willing to give written informed consent

•ï??Any dermatological condition of the scalp other than hair loss and /or dandruff.
•ï??Prior use of scalp hair growth treatment (e.g., finasteride, minoxidil) within 6 months
•ï??Any prior hair growth procedures (e.g., hair transplant or laser)
•ï??History of alcohol or drug addiction
•ï??History of skin allergy
•ï??Regular use of medication which might interfere with the results of the study
•ï??Subject had used phytotherapy (e.g., saw palmetto) within eight weeks prior to baseline.
•ï??Any active skin infection in the scalp area or scarring in the target area.
•ï??Photosensitivity to laser light.
•ï??Subjects with psoriasis/seborrheic dermatitis